Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease ...

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

Whether you wear it alone or as part of a stack, you'll be rocking this gold bracelet on the regular. Featuring small interlocking chains, this dainty piece is fully adjustable for a the perfect fit.

The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers ...

Spanning nearly 100 laboratories in 45 countries, landmark research has, for the first time, shown an association between genetic brain size and neurological conditions such as Parkinson's disease ...

The therapy is delivered as a 24-hour continuous infusion to treat motor fluctuations in adults with advanced Parkinson’s. AbbVie already markets a carbidopa and levodopa combination with Duopa.

From his knowledge, skill and willingness to share to his long fight with Parkinson’s disease, he was a beacon of strength,” Eggert, 52, told The Post in a statement Tuesday. “The beaches ...

MeiraGTx is looking to march its Parkinson’s disease treatment forward into phase 3 after the gene therapy improved motor ability and quality of life in a small midphase trial. A total of 14 ...

Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 8, 2024 ...